COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
The European Myeloma Network recommends all patients with monoclonal gammopathy of unknown significance, smouldering multiple myeloma, multiple myeloma, and monoclonal gammopathies of clinical significance should be vaccinated with a COVID vaccine.
Source:
The Lancet Haematology
SPS commentary:
The recommendations discuss when preferably these patients should be vaccinated (e.g. during well-controlled disease; during periods without therapy), the risk factors for poor response that should be considered, and actions to take in the case of immune impairment (e.g. administer a third vaccine dose).